Skip to main content

NSRX · Nasus Pharma Ltd · Short Volume

Track NSRX — free
$3.40 +0.05 (+1.64%) At close · Sep 11
Market Cap
$39.88M
Shares
11.71M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-09-11 333 30 3,168 10.5%
2026-09-10 1,976 127 8,616 22.9%
2026-09-09 796 530 1,329 59.9%
2026-09-08 919 0 7,303 12.6%
2026-09-04 360 0 568 63.4%
2026-09-03 1,390 3 5,137 27.1%
2026-09-02 256 9 1,088 23.5%
2026-09-01 6,008 0 11,027 54.5%
2026-08-31 279 0 2,256 12.4%
2026-08-28 1,073 500 8,549 12.6%
2026-08-27 413 0 4,173 9.9%
2026-08-26 592 0 1,789 33.1%
2026-08-25 1,401 0 3,852 36.4%
2026-08-24 1,883 0 8,077 23.3%
2026-08-21 4,456 0 19,547 22.8%
2026-08-20 1,813 262 8,154 22.2%
2026-08-19 10,021 1,420 18,667 53.7%
2026-08-18 4,345 0 11,961 36.3%
2026-08-17 344 0 1,587 21.7%
2026-08-14 11,882 0 19,805 60.0%
2026-08-13 1,103 0 2,596 42.5%
2026-08-12 376 0 2,500 15.0%
2026-08-11 1,204 0 2,444 49.3%
2026-08-10 3,016 0 9,073 33.2%
2026-08-07 1,981 0 3,647 54.3%
2026-08-06 2,252 400 4,294 52.5%
2026-08-05 2,236 299 4,698 47.6%
2026-08-04 20,702 0 25,396 81.5%
2026-08-03 881 0 4,858 18.1%
2026-07-31 619 0 2,780 22.3%
2026-07-30 764 0 1,408 54.3%
2026-07-29 2,564 0 5,541 46.3%
2026-07-28 2,067 0 11,501 18.0%
2026-07-27 1,915 0 8,378 22.9%
2026-07-24 475 0 5,240 9.1%
2026-07-23 2,388 0 7,745 30.8%
2026-07-22 1,386 0 2,330 59.5%
2026-07-21 232 0 2,104 11.1%
2026-07-20 448 0 2,301 19.5%
2026-07-17 442 0 4,930 9.0%
2026-07-16 1,570 0 2,169 72.4%
2026-07-15 95 0 5,938 1.6%
2026-07-14 3,258 127 8,107 40.2%
2026-07-13 8,179 0 13,198 62.0%
2026-07-10 1,060 0 8,334 12.7%
2026-07-09 2,797 0 16,701 16.7%
2026-07-08 1,371 449 8,603 15.9%
2026-07-07 1,048 0 11,729 8.9%
2026-07-06 1,697 0 4,950 34.3%
2026-07-02 1,498 0 9,902 15.1%
Showing 1–50 of 62 days
Key facts CIK 2029039 CUSIP M7071P109 13F (30d) 6 filings 6 filers Visit website Investor relations